In stroke, IL-10 modulates the immune response by inhibiting the synthesis of pro-inflammatory cytokines (e.g., IL-1β, IL-6, TNF-α), suppressing antigen presentation, and downregulating adhesion molecules on endothelial cells. This evidence concerns the gene IL1B and stroke disorder.